Science

Sleep apnea implants for tongue to be tested

Loud snoring can signal sleep apnea, depriving sufferers of enough sleep to trigger a car crash, even a heart attack, but now scientists are beginning to test if an implanted pacemaker-like device might help.
A remote control unit turns on an experimental nerve stimulator to combat sleep apnea. Scientists are testing if the implanted device might help keep sufferers' airways open by zapping the tongue during sleep. ((Associated Press) )

Loud snoring can signal sleep apnea, depriving sufferers of enough sleep to trigger a car crash, even a heart attack, but now scientists are beginning to test if an implanted pacemaker-like device might help.

The device is designed to keep the airways open by zapping the tongue during sleep.

Wait, what does your tongue have to do with a good night's sleep?

One of the main causes of obstructive sleep apnea is that the tongue and throat muscles relax too much during sleep, enough to temporarily collapse and block breathing for 30 seconds or so at a time. The person jerks awake and gasps, a cycle that can repeat itself 30 or more times an hour, depriving patients of crucial deep sleep.

The idea behind the experimental implant: Stimulate the nerve that controls the base of the tongue with a mild electrical current during sleep, and maybe it will stay toned and in place like it does during the day rather than becoming floppy.

By the end of January, Minneapolis-based Inspire Medical Systems plans to begin enrolling 100 apnea patients in a key study in the U.S. and Europe to see if so-called hypoglossal nerve stimulation really could work.

Looking for cure

Two competitors are developing similar implants: ImThera Medical of San Diego says it hopes to begin U.S. studies later next year, and Apnex Medical of St. Paul, Minn., has announced some small-scale testing.

"In this kind of research, we're not looking for little changes," says Dr. Meir Kryger, a sleep medicine specialist at Gaylord Hospital in Connecticut, who is helping to lead Inspire's study. "What we're looking for is actually cure." 

Inspire's experimental implant stimulates the nerve that controls the base of the tongue with a mild electrical current during sleep. ((Courtesy of Inspire) )

More than 12 million Americans have obstructive sleep apnea, according to the U.S. National Institutes of Health. It's particularly common in people who are overweight and in middle-aged men, but anyone can have it. According to the 2009 Canadian Community Health Survey, 26 per cent of Canadian adults had a high risk of having obstructive sleep apnea.

Today's undisputed best treatment, called CPAP, uses special bedtime masks to gently blow air through the nose to keep airways open. But studies suggest at least 30 per cent of diagnosed apnea patients won't or can't use CPAP. They cite masks that fit poorly and leak, or say they feel claustrophobic, or rip them off while tossing and turning during the night.

Yet going untreated is more dangerous than just feeling tired. Sleep apnea stresses the body in ways that increase the risk of high blood pressure, heart attack, stroke and diabetes. More immediately, severe apnea increases the chance of a car crash sevenfold.

Last year, the U.S. National Transportation Safety Board recommended that pilots, truck drivers and other commercial transportation operators start being screened for apnea, saying it has been a factor in incidents involving every mode of transit.

'No idea it's on'

Surgeons sometimes try removing part of the roof of the mouth or other soft tissues to treat apnea by widening airways. But it's hard to predict when these difficult operations will help, so they're usually reserved for the most severe cases.

Enter hypoglossal nerve stimulation.

With Inspire's system, doctors implant a small pacemaker-like generator under the skin near the collarbone, and snake a wire up under the jaw to that tongue-controlling nerve. A sensor at the diaphragm detects when a patient takes a breath, signaling the implant to zap the nerve.

Researchers adjust the power so that the nerve is stimulated just enough to keep the tongue from falling backward during sleep but not to stick out.

Patients turn on the device at bedtime with a remote control, complete with a timer they can set so they fall asleep before the pulses begin.

"I don't have any idea while I'm sleeping that it's on," says Rik Krohn, 67, a Minneapolis man who'd given up on apnea treatment until volunteering for an early Inspire study last year — and says he now gets a good night's sleep. "It's a game-changer for me."

A caveat: Potential participants in Inspire's upcoming study must undergo a special exam where a tube snaked down the airway documents whether a tongue collapse or a problem with some other tissue is the true cause of their apnea, stresses Connecticut's Kryger.

Obstructive sleep apnea can be treated by continuous positive airway pressure (CPAP). Special bedtime masks gently blow air through the nose to keep airways open. But studies suggest at least 30 per cent of diagnosed apnea patients won't or can't use CPAP. (iStock)